Yuki Tahata
0000-0002-9116-7054
Osaka
6 papers found
Refreshing results…
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan
Prognostic impact of worsening of esophageal varices after balloon‐occluded retrograde transvenous obliteration
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
Missing publications? Search for publications with a matching author name.